Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment‐Naive Subjects with HIV‐1 Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment‐Naive Subjects with HIV‐1 Infection

Published:2008-10-15 Issue:8 Volume:198 Page:1113-1122
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Landovitz Raphael J.,Angel Jonathan B.,Hoffmann Christian,Horst Heinz,Opravil Milos,Long Jianmin,Greaves Wayne,Fätkenheuer Gerd

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/198/8/1113/18054908/198-8-1113.pdf

Reference39 articles.

1. Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

2. The Epidemiology of Antiretroviral Drug Resistance among Drug‐Naive HIV‐1–Infected Persons in 10 US Cities

3. Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

4. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses;European Journal of Medicinal Chemistry;2024-02

2. CCL5/CCR5 axis in human diseases and related treatments;Genes & Diseases;2022-01

3. Co-receptor signaling in the pathogenesis of neuroHIV;Retrovirology;2021-08-24

4. Host-Directed Antiviral Therapy;Clinical Microbiology Reviews;2020-06-17

5. Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials;Antiviral Chemistry and Chemotherapy;2019-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3